Switch to:

Sangamo Therapeutics Asset Impairment Charge

: $0.0 Mil (TTM As of Jun. 2020)
View and export this data going back to 2000. Start your Free Trial

Sangamo Therapeutics's Asset Impairment Charge for the three months ended in Jun. 2020 was $0.0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2020 was $0.0 Mil.


Sangamo Therapeutics Asset Impairment Charge Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Sangamo Therapeutics Annual Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Asset Impairment Charge Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.87 0.00 0.00 0.00 0.00

Sangamo Therapeutics Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Asset Impairment Charge Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Sangamo Therapeutics Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2020 was 0 (Sep. 2019 ) + 0 (Dec. 2019 ) + 0 (Mar. 2020 ) + 0 (Jun. 2020 ) = $0.0 Mil.


Sangamo Therapeutics Asset Impairment Charge Related Terms


Sangamo Therapeutics Asset Impairment Charge Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)